+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Cell Therapies"

Cancer Immunotherapy Market - Global Forecast 2025-2032 - Product Thumbnail Image

Cancer Immunotherapy Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 192 Pages
  • Global
From
From
Cancer Immunotherapy Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Cancer Immunotherapy Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 197 Pages
  • Global
From
Blood Cancer Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Blood Cancer Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 182 Pages
  • Global
From
Cellular Immunotherapy Market - Global Forecast 2025-2032 - Product Thumbnail Image

Cellular Immunotherapy Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 185 Pages
  • Global
From
Cancer Biological Therapy Market - Global Forecast 2025-2032 - Product Thumbnail Image

Cancer Biological Therapy Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 199 Pages
  • Global
From
Stomach Cancer Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Stomach Cancer Treatment Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 184 Pages
  • Global
From
Oncology Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Oncology Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 198 Pages
  • Global
From
Cancer Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Cancer Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 183 Pages
  • Global
From
Malignant Mesothelioma Market - Global Forecast 2025-2032 - Product Thumbnail Image

Malignant Mesothelioma Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 189 Pages
  • Global
From
From
CAR T-cell Therapy Market - Global Forecast 2025-2032 - Product Thumbnail Image

CAR T-cell Therapy Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 189 Pages
  • Global
From
Gastric Cancer Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Gastric Cancer Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 183 Pages
  • Global
From
Immune Checkpoint Inhibitors Market - Global Forecast 2025-2032 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 191 Pages
  • Global
From
Thyroid Cancer Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Thyroid Cancer Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 195 Pages
  • Global
From
From
Ewing Sarcoma Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Ewing Sarcoma Therapeutics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 182 Pages
  • Global
From
Anti-Tumor Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Anti-Tumor Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 184 Pages
  • Global
From
CD Antigen Cancer Therapy Market - Global Forecast 2025-2032 - Product Thumbnail Image

CD Antigen Cancer Therapy Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 186 Pages
  • Global
From
From
Loading Indicator

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more